candesartan cilexetil and hydrochlorothiazide
Generic: candesartan cilexetil and hydrochlorothiazide
Labeler: mylan pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
candesartan cilexetil and hydrochlorothiazide
Generic Name
candesartan cilexetil and hydrochlorothiazide
Labeler
mylan pharmaceuticals inc.
Dosage Form
TABLET
Routes
Active Ingredients
candesartan cilexetil 16 mg/1, hydrochlorothiazide 12.5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0378-3001
Product ID
0378-3001_b308024b-d9c2-4b12-ac28-cb2e295ab1bf
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA090704
Marketing Start
2012-12-04
Marketing End
2027-02-28
Pharmacologic Class
Established (EPC)
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
03783001
Hyphenated Format
0378-3001
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
candesartan cilexetil and hydrochlorothiazide (source: ndc)
Generic Name
candesartan cilexetil and hydrochlorothiazide (source: ndc)
Application Number
ANDA090704 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 16 mg/1
- 12.5 mg/1
Packaging
- 90 TABLET in 1 BOTTLE, PLASTIC (0378-3001-77)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b308024b-d9c2-4b12-ac28-cb2e295ab1bf", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0303783003771", "0303783001777", "0303783002774"], "unii": ["0J48LPH2TH", "R85M2X0D68"], "rxcui": ["578325", "578330", "802749"], "spl_set_id": ["f3c4f7ed-e667-4528-a675-b032c2a4425d"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE, PLASTIC (0378-3001-77)", "package_ndc": "0378-3001-77", "marketing_end_date": "20270228", "marketing_start_date": "20121204"}], "brand_name": "Candesartan Cilexetil and Hydrochlorothiazide", "product_id": "0378-3001_b308024b-d9c2-4b12-ac28-cb2e295ab1bf", "dosage_form": "TABLET", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "0378-3001", "generic_name": "candesartan cilexetil and hydrochlorothiazide", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Candesartan Cilexetil and Hydrochlorothiazide", "active_ingredients": [{"name": "CANDESARTAN CILEXETIL", "strength": "16 mg/1"}, {"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}], "application_number": "ANDA090704", "marketing_category": "ANDA", "marketing_end_date": "20270228", "marketing_start_date": "20121204"}